0.006
0.00 (-14.29%)
| 前收盘价格 | 0.007 |
| 收盘价格 | 0.006 |
| 成交量 | 184,117 |
| 平均成交量 (3个月) | 5,751,374 |
| 市值 | 15,245,100 |
| 价格/销量 (P/S) | 1.87 |
| 股市价格/股市净资产 (P/B) | 1.15 |
| 52周波幅 | |
| 利润日期 | 12 Feb 2025 - 17 Feb 2025 |
| 营业毛利率 | -87.42% |
| 营业利益率 (TTM) | -65.58% |
| 稀释每股收益 (EPS TTM) | 0.000 |
| 季度收入增长率 (YOY) | 173.40% |
| 流动比率 (MRQ) | 0.940 |
| 营业现金流 (OCF TTM) | -2.08 M |
| 杠杆自由现金流 (LFCF TTM) | -1.42 M |
| 资产报酬率 (ROA TTM) | -56.57% |
| 股东权益报酬率 (ROE TTM) | -1,064.19% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Packaged Foods (AU) | 混合的 | 混合的 |
| Packaged Foods (全球的) | 混合的 | 混合的 | |
| 股票 | CALMERCOIN FPO [CCO] | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 1.0 |
| 平均 | 0.38 |
|
The Calmer Co International Ltd is mainly engaged in the research, development, and selling of kava extracts as a consumer product. Its business objective is the primary production of kava through a network of outsourced kava farms and via its Farm located in Fiji and the production and sale of kava supplements and complementary medicines. The company has produced three types of products in the market: shots, powders, and capsules. Its reportable segments are; Fiji Kava Australia Trading Pty Ltd (Fiji Kava Australia Trading) which derives maximum revenue, South Pacific Elixirs Pty Limited (SPE Fiji), Fiji Kava Inc (USA), and Danodan Hempworks LLC (USA). Geographically, it derives key revenue from Australia and the rest from Fiji, and other regions. |
|
| 部门 | Consumer Defensive |
| 行业 | Packaged Foods |
| 投资方式 | Small Value |
| 内部持股比例 | 37.66% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合